The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Implantable Collamer Lens Market Projected To Expand During 2026–2030?
The market for implantable collamer lenses has experienced substantial growth in recent times. This market is projected to expand, reaching $22.2 billion in 2026 from $20.77 billion in 2025, at a compound annual growth rate (CAGR) of 6.9%. Key drivers for this past growth include the escalating prevalence of refractive vision disorders, a heightened demand for surgical vision correction, innovations in ophthalmic implant technology, the increasing adoption of icl procedures, and the broadening reach of specialized ophthalmic clinics.
The implantable collamer lens market is projected to experience robust expansion over the coming years. By 2030, its value is anticipated to reach $28.74 billion, expanding at a compound annual growth rate (CAGR) of 6.7%. This anticipated growth is primarily driven by factors such as the increasing uptake of high-end vision correction methods, a heightened emphasis on less invasive ophthalmic surgical techniques, the broadening scope of elective eye care services, increased funding into cutting-edge ophthalmology technologies, and a greater understanding among patients regarding the advantages of icl benefits. Key trends expected during this period involve a greater acceptance of evo implantable collamer lenses, the increasing application of laser-assisted implantation methods, a surging need for vision correction options that can be reversed, the development of more personalized lens designs, and a stronger emphasis on ensuring enduring visual stability.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp
What Influential Factors Are Boosting The Implantable Collamer Lens Market Demand?
The increasing occurrence of vision impairments is anticipated to propel the implantable collamer lens market in the coming years. These disorders are conditions that impair clear sight, marked by a progressive decrease in visual sharpness and overall eye well-being. Globally, vision disorders are on the rise, attributed to factors including an aging demographic, extended screen usage, and the growing incidence of conditions such as myopia and age-related macular degeneration. Implantable Collamer Lenses (ICLs) present an effective remedy for rectifying vision issues like myopia, hyperopia, and astigmatism, providing a secure and reversible option compared to conventional refractive surgeries such as LASIK. For example, in August 2023, a report from the World Health Organization, a Switzerland-based specialized agency of the United Nations, indicated that globally, more than 2.2 billion individuals experience near or distance vision impairment, and 1 billion of these instances are either preventable or yet to be addressed. Consequently, the growing occurrence of vision impairments is fostering the expansion of the implantable collamer lens market.
What Segment Categories Are Evaluated In The Implantable Collamer Lens Market Study?
The implantable collamer lens market covered in this report is segmented –
1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)
2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques
3) By Application: Myopia, Hyperopia, Astigmatism
4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User
Subsegments:
1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia
2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia
What Trends Are Influencing The Future Of The Implantable Collamer Lens Market?
Leading companies in the implantable collamer lens market are prioritizing technological advancements, such as biocompatible, minimally invasive lens implants that rectify a wide array of refractive errors without removing corneal tissue, to enhance patient outcomes and reduce reliance on glasses and contact lenses. Biocompatible Minimally Invasive Implantable Lenses facilitate secure, reversible vision correction by integrating with the eye’s natural anatomy, delivering swift procedures and elevated patient satisfaction. For instance, in March 2024, STAAR Surgical Company, a U.S.-based ophthalmic medical device company, disclosed that more than three million EVO ICL lenses have been implanted globally. The EVO ICL addresses myopia, with or without astigmatism, and presbyopia, through a 20–30 minute intervention where the lens is positioned between the iris and the natural crystalline lens. This biocompatible, removable lens serves as a cutting-edge substitute for glasses and contacts, assisting millions of patients in achieving improved vision securely and effectively.
Who Are The Firms Contributing To The Implantable Collamer Lens Market Ecosystem?
Major companies operating in the implantable collamer lens market are STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen)*, Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, Visiogen Inc.
Access The Complete Implantable Collamer Lens Market Report:
https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report
Which Region Leads The Implantable Collamer Lens Market By Size?
North America was the largest region in the implantable collamer lens market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Implantable Collamer Lens Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report
Browse Through More Reports Similar to the Global Implantable Collamer Lens Market 2026, By The Business Research Company
Corneal Implants Market Report 2026
https://www.thebusinessresearchcompany.com/report/corneal-implants-global-market-report
Prescription Lens Market Report 2026
https://www.thebusinessresearchcompany.com/report/prescription-lens-global-market-report
Cataract Surgery Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model